Psycho-Babble Medication Thread 1121894

Shown: posts 1 to 1 of 1. This is the beginning of the thread.


New antidepressants in the pipeline?

Posted by SLS on March 11, 2023, at 10:59:44

There are novel antidepressants coming up the pipieline - finally.

Here are two that should be out soon. Each uses a different mechanism of action.


ESMETHADONE - NMDA receptor antagonist

Relmada's lead program, REL-1017 (esmethadone), is a new chemical entity (NCE) and novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission.


Relmada Therapeutics Receives FDA Fast Track Designation for REL-1017 as a Monotherapy for the Treatment of Major Depressive Disorder


REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical Study


ZURANOLONE - positive allosteric modulator of GABA receptors.

Zuranolone is an investigational drug being evaluated as a 14-day, rapid-acting, once-daily, oral treatment in adults with MDD and PPD. The application has been granted priority review and the FDA has assigned a Prescription Drug User Fee Act (PDUFA) action date of August 5, 2023.Feb 6

Boarding priority review track, Biogen and Sage get August 5th decision date for depression drug approval

There are several others that look good. Now, no one can say that they have tried every drug.

Please wait for these novel compounds to work their way up the ladder. It is not certain that you will fail to respond to drugs you have never tried before, and whose mechanisms of action are novel to your brain. There is a new potent dopamine reuptake inhibitor coming out with relatively low potencies at the NE and 5-HT transporters. At the moment, I can't remember its name.

We were in a slump for 20 years. I like having options, too, despite my currently being in remission. Sometimes antidepressants stop working for no obvious reason.

- Scott

This is the end of the thread.

Show another thread

URL of post in thread:

Psycho-Babble Medication | Extras | FAQ

[dr. bob] Dr. Bob is Robert Hsiung, MD,

Script revised: February 4, 2008
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.